Engineering Antibody Oligonucleotide Conjugates (AOCs): Preclinical, Clinical Progress and Lessons Learned
Time: 2:15 pm
day: Conference Day Two
Details:
- Discussing antibody oligonucleotide conjugates and exploring how AOCs can help solve oligo delivery challenges
- Developing cellular and animal models with relevant disease readouts to demonstrate target engagement;
- AOC development candidate selection and clinical progress
